

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle tissue regeneration (GO:0043403) | 9.78739263 |
| 2 | negative regulation of skeletal muscle tissue development (GO:0048642) | 9.39447697 |
| 3 | regulation of skeletal muscle contraction (GO:0014819) | 9.26553658 |
| 4 | response to muscle activity (GO:0014850) | 8.73801009 |
| 5 | actin-mediated cell contraction (GO:0070252) | 8.16049636 |
| 6 | cellular response to dexamethasone stimulus (GO:0071549) | 6.75427975 |
| 7 | response to activity (GO:0014823) | 6.25983729 |
| 8 | response to dexamethasone (GO:0071548) | 6.23866579 |
| 9 | striated muscle adaptation (GO:0014888) | 5.96854650 |
| 10 | actin filament-based movement (GO:0030048) | 5.90001970 |
| 11 | protein K6-linked ubiquitination (GO:0085020) | 5.53224385 |
| 12 | dosage compensation (GO:0007549) | 5.41522460 |
| 13 | negative regulation of organelle assembly (GO:1902116) | 5.18787241 |
| 14 | muscle adaptation (GO:0043500) | 4.82248894 |
| 15 | regulation of muscle hypertrophy (GO:0014743) | 4.82064724 |
| 16 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.66053598 |
| 17 | regulation of DNA methylation (GO:0044030) | 4.57317830 |
| 18 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.38682916 |
| 19 | myotube cell development (GO:0014904) | 4.34589921 |
| 20 | skeletal muscle contraction (GO:0003009) | 4.31504668 |
| 21 | regulation of gene expression by genetic imprinting (GO:0006349) | 4.30672078 |
| 22 | protein trimerization (GO:0070206) | 4.28791708 |
| 23 | positive regulation of histone H3-K4 methylation (GO:0051571) | 4.28579429 |
| 24 | muscle organ development (GO:0007517) | 4.03810960 |
| 25 | response to electrical stimulus (GO:0051602) | 3.99752398 |
| 26 | muscle structure development (GO:0061061) | 3.98728313 |
| 27 | dendritic spine morphogenesis (GO:0060997) | 3.95446785 |
| 28 | regulation of relaxation of muscle (GO:1901077) | 3.91386873 |
| 29 | tissue regeneration (GO:0042246) | 3.79172167 |
| 30 | negative regulation of histone methylation (GO:0031061) | 3.77747993 |
| 31 | skeletal muscle fiber development (GO:0048741) | 3.72170514 |
| 32 | response to inactivity (GO:0014854) | 3.71356986 |
| 33 | cellular response to ketone (GO:1901655) | 3.64686071 |
| 34 | negative regulation of striated muscle tissue development (GO:0045843) | 3.50659641 |
| 35 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.48038762 |
| 36 | genetic imprinting (GO:0071514) | 3.45581692 |
| 37 | response to testosterone (GO:0033574) | 3.45037688 |
| 38 | negative regulation of muscle tissue development (GO:1901862) | 3.41671368 |
| 39 | protein polyglutamylation (GO:0018095) | 3.41050184 |
| 40 | heparin metabolic process (GO:0030202) | 3.39679689 |
| 41 | heparin biosynthetic process (GO:0030210) | 3.39679689 |
| 42 | ganglion development (GO:0061548) | 3.39063587 |
| 43 | growth hormone secretion (GO:0030252) | 3.38529640 |
| 44 | negative regulation of histone acetylation (GO:0035067) | 3.37090496 |
| 45 | cellular response to glucocorticoid stimulus (GO:0071385) | 3.34892467 |
| 46 | regulation of histone H3-K9 methylation (GO:0051570) | 3.32989829 |
| 47 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.32708374 |
| 48 | muscle system process (GO:0003012) | 3.32477626 |
| 49 | regulation of centriole replication (GO:0046599) | 3.31014355 |
| 50 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.29891330 |
| 51 | negative regulation of muscle organ development (GO:0048635) | 3.24743165 |
| 52 | auditory behavior (GO:0031223) | 3.21327944 |
| 53 | muscle contraction (GO:0006936) | 3.19184352 |
| 54 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 3.18210447 |
| 55 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.14987157 |
| 56 | cerebral cortex neuron differentiation (GO:0021895) | 3.10518650 |
| 57 | cellular response to corticosteroid stimulus (GO:0071384) | 3.09058169 |
| 58 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.07695468 |
| 59 | regulation of timing of cell differentiation (GO:0048505) | 3.06429034 |
| 60 | lung secretory cell differentiation (GO:0061140) | 3.04484334 |
| 61 | regulation of synapse structural plasticity (GO:0051823) | 3.00274942 |
| 62 | response to folic acid (GO:0051593) | 2.79883621 |
| 63 | viral genome replication (GO:0019079) | 2.73288042 |
| 64 | synaptic vesicle maturation (GO:0016188) | 2.67944491 |
| 65 | positive regulation of growth hormone secretion (GO:0060124) | 2.66731723 |
| 66 | calcium ion import (GO:0070509) | 2.64772381 |
| 67 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.63861832 |
| 68 | negative regulation of protein acetylation (GO:1901984) | 2.57885459 |
| 69 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.56873685 |
| 70 | secondary heart field specification (GO:0003139) | 2.56689969 |
| 71 | heart field specification (GO:0003128) | 2.56689969 |
| 72 | muscle fiber development (GO:0048747) | 2.54930894 |
| 73 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.53195901 |
| 74 | myoblast fusion (GO:0007520) | 2.51154900 |
| 75 | striated muscle contraction (GO:0006941) | 2.51146212 |
| 76 | regulation of development, heterochronic (GO:0040034) | 2.50436809 |
| 77 | multicellular organismal movement (GO:0050879) | 2.49715609 |
| 78 | musculoskeletal movement (GO:0050881) | 2.49715609 |
| 79 | dendritic spine organization (GO:0097061) | 2.48380647 |
| 80 | regulation of transcription involved in cell fate commitment (GO:0060850) | 2.47312386 |
| 81 | protein localization to microtubule (GO:0035372) | 2.43810116 |
| 82 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.43381242 |
| 83 | negative regulation of developmental growth (GO:0048640) | 2.40376391 |
| 84 | postsynaptic membrane organization (GO:0001941) | 2.39014690 |
| 85 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.33721620 |
| 86 | mechanosensory behavior (GO:0007638) | 2.33579058 |
| 87 | postreplication repair (GO:0006301) | 2.32962543 |
| 88 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.32297825 |
| 89 | muscle cell cellular homeostasis (GO:0046716) | 2.29061489 |
| 90 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.28685151 |
| 91 | regulation of muscle system process (GO:0090257) | 2.28463228 |
| 92 | embryonic cranial skeleton morphogenesis (GO:0048701) | 2.27109448 |
| 93 | regulation of striated muscle contraction (GO:0006942) | 2.25711366 |
| 94 | response to gravity (GO:0009629) | 15.3541719 |
| 95 | skeletal muscle adaptation (GO:0043501) | 13.3325010 |
| 96 | striated muscle atrophy (GO:0014891) | 12.9468311 |
| 97 | negative regulation of muscle hypertrophy (GO:0014741) | 11.7698655 |
| 98 | muscle atrophy (GO:0014889) | 11.5458702 |
| 99 | muscle filament sliding (GO:0030049) | 10.0040176 |
| 100 | actin-myosin filament sliding (GO:0033275) | 10.0040176 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_22108803_ChIP-Seq_LS180_Human | 7.82757217 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.98827014 |
| 3 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 4.74743419 |
| 4 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 4.64476378 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 4.03306784 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.68003207 |
| 7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.53874191 |
| 8 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.39919402 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.13049962 |
| 10 | FUS_26573619_Chip-Seq_HEK293_Human | 2.73617035 |
| 11 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.68548856 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.50140211 |
| 13 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.49697348 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.48186060 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.31205809 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.09876396 |
| 17 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.04579475 |
| 18 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.94848802 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.85935404 |
| 20 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.81817216 |
| 21 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.80512773 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.77601958 |
| 23 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.77241414 |
| 24 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.74495124 |
| 25 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.74443056 |
| 26 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.72540688 |
| 27 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.70235931 |
| 28 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.70116211 |
| 29 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.70116211 |
| 30 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.62560827 |
| 31 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.62392571 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.60917115 |
| 33 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.57765729 |
| 34 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.52517894 |
| 35 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.45950333 |
| 36 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.45514389 |
| 37 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.44247601 |
| 38 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.43198151 |
| 39 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.41345369 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.40429014 |
| 41 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.37304111 |
| 42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.36533473 |
| 43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.35346433 |
| 44 | MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 1.34810450 |
| 45 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.33938546 |
| 46 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.32663980 |
| 47 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.32663980 |
| 48 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.32663980 |
| 49 | RXR_22108803_ChIP-Seq_LS180_Human | 1.30777357 |
| 50 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.25757860 |
| 51 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.24063463 |
| 52 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.20746998 |
| 53 | KDM2B_26808549_Chip-Seq_REH_Human | 1.18177043 |
| 54 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.15721708 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15588423 |
| 56 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.14821479 |
| 57 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.12780598 |
| 58 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.12726576 |
| 59 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.12714203 |
| 60 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.12513965 |
| 61 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.12192942 |
| 62 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.11912441 |
| 63 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.09144003 |
| 64 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.08836861 |
| 65 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.07853615 |
| 66 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.03871908 |
| 67 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03265572 |
| 68 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03113012 |
| 69 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.02764981 |
| 70 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.02022043 |
| 71 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.00665988 |
| 72 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.00541701 |
| 73 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00321977 |
| 74 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.99181594 |
| 75 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.98338678 |
| 76 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.97205455 |
| 77 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97205455 |
| 78 | STAT3_23295773_ChIP-Seq_U87_Human | 0.97132795 |
| 79 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94496953 |
| 80 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.89678199 |
| 81 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.87021031 |
| 82 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86346924 |
| 83 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.85249571 |
| 84 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.83764939 |
| 85 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.81638073 |
| 86 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.81283511 |
| 87 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.80599853 |
| 88 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.80139474 |
| 89 | TCF4_23295773_ChIP-Seq_U87_Human | 0.79892568 |
| 90 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.79719637 |
| 91 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79017349 |
| 92 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.78142766 |
| 93 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.78002234 |
| 94 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.77905824 |
| 95 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.77551686 |
| 96 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.77020338 |
| 97 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76913130 |
| 98 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.76695558 |
| 99 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.76620730 |
| 100 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.74004235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 5.27960022 |
| 2 | MP0000747_muscle_weakness | 5.19483349 |
| 3 | MP0002089_abnormal_postnatal_growth/wei | 4.63575952 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 4.10666701 |
| 5 | MP0004036_abnormal_muscle_relaxation | 3.96848042 |
| 6 | MP0002269_muscular_atrophy | 3.53529609 |
| 7 | MP0000749_muscle_degeneration | 3.37428141 |
| 8 | MP0000759_abnormal_skeletal_muscle | 3.34326965 |
| 9 | MP0000566_synostosis | 3.18807208 |
| 10 | MP0004270_analgesia | 3.15686645 |
| 11 | MP0005083_abnormal_biliary_tract | 2.99581415 |
| 12 | MP0002108_abnormal_muscle_morphology | 2.78244736 |
| 13 | MP0002822_catalepsy | 2.73570663 |
| 14 | MP0004087_abnormal_muscle_fiber | 2.55778064 |
| 15 | MP0002106_abnormal_muscle_physiology | 2.49039257 |
| 16 | MP0005620_abnormal_muscle_contractility | 2.37384219 |
| 17 | MP0003959_abnormal_lean_body | 2.07481214 |
| 18 | MP0005369_muscle_phenotype | 1.96395770 |
| 19 | MP0000751_myopathy | 1.87589588 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 1.83305937 |
| 21 | MP0003787_abnormal_imprinting | 1.72908061 |
| 22 | MP0008789_abnormal_olfactory_epithelium | 1.69294058 |
| 23 | MP0000750_abnormal_muscle_regeneration | 1.63913643 |
| 24 | MP0002638_abnormal_pupillary_reflex | 1.62183051 |
| 25 | MP0000427_abnormal_hair_cycle | 1.60057764 |
| 26 | MP0002095_abnormal_skin_pigmentation | 1.53709861 |
| 27 | MP0001968_abnormal_touch/_nociception | 1.50457497 |
| 28 | MP0002896_abnormal_bone_mineralization | 1.49323596 |
| 29 | MP0000733_abnormal_muscle_development | 1.47249190 |
| 30 | MP0000778_abnormal_nervous_system | 1.45722314 |
| 31 | MP0003646_muscle_fatigue | 1.43990997 |
| 32 | MP0006072_abnormal_retinal_apoptosis | 1.43073851 |
| 33 | MP0002734_abnormal_mechanical_nocicepti | 1.32766707 |
| 34 | MP0005423_abnormal_somatic_nervous | 1.32125606 |
| 35 | MP0000049_abnormal_middle_ear | 1.30623177 |
| 36 | MP0003045_fibrosis | 1.28647407 |
| 37 | MP0004130_abnormal_muscle_cell | 1.26659141 |
| 38 | MP0002736_abnormal_nociception_after | 1.25616441 |
| 39 | MP0000372_irregular_coat_pigmentation | 1.19920184 |
| 40 | MP0003937_abnormal_limbs/digits/tail_de | 1.16067597 |
| 41 | MP0004142_abnormal_muscle_tone | 1.15257199 |
| 42 | MP0000013_abnormal_adipose_tissue | 1.11095889 |
| 43 | MP0004484_altered_response_of | 1.04057848 |
| 44 | MP0003950_abnormal_plasma_membrane | 1.01929285 |
| 45 | MP0003880_abnormal_central_pattern | 1.01654203 |
| 46 | MP0005499_abnormal_olfactory_system | 1.00964913 |
| 47 | MP0005394_taste/olfaction_phenotype | 1.00964913 |
| 48 | MP0009745_abnormal_behavioral_response | 1.00302088 |
| 49 | MP0002733_abnormal_thermal_nociception | 0.99687247 |
| 50 | MP0001529_abnormal_vocalization | 0.97566053 |
| 51 | MP0005646_abnormal_pituitary_gland | 0.96447986 |
| 52 | MP0000631_abnormal_neuroendocrine_gland | 0.95010039 |
| 53 | MP0000470_abnormal_stomach_morphology | 0.93009556 |
| 54 | MP0009250_abnormal_appendicular_skeleto | 0.91440403 |
| 55 | MP0001905_abnormal_dopamine_level | 0.89058073 |
| 56 | MP0004885_abnormal_endolymph | 0.88888387 |
| 57 | MP0004084_abnormal_cardiac_muscle | 0.87934591 |
| 58 | MP0000955_abnormal_spinal_cord | 0.84861883 |
| 59 | MP0003635_abnormal_synaptic_transmissio | 0.82426987 |
| 60 | MP0002837_dystrophic_cardiac_calcinosis | 0.81762290 |
| 61 | MP0005386_behavior/neurological_phenoty | 0.80718077 |
| 62 | MP0004924_abnormal_behavior | 0.80718077 |
| 63 | MP0005167_abnormal_blood-brain_barrier | 0.79413795 |
| 64 | MP0001943_abnormal_respiration | 0.77717838 |
| 65 | MP0006276_abnormal_autonomic_nervous | 0.76998287 |
| 66 | MP0003755_abnormal_palate_morphology | 0.76443362 |
| 67 | MP0002184_abnormal_innervation | 0.76159106 |
| 68 | MP0003123_paternal_imprinting | 0.75666317 |
| 69 | MP0005645_abnormal_hypothalamus_physiol | 0.75207901 |
| 70 | MP0000467_abnormal_esophagus_morphology | 0.74389486 |
| 71 | MP0002114_abnormal_axial_skeleton | 0.74141661 |
| 72 | MP0003385_abnormal_body_wall | 0.72151262 |
| 73 | MP0004215_abnormal_myocardial_fiber | 0.71705819 |
| 74 | MP0003786_premature_aging | 0.68698651 |
| 75 | MP0000537_abnormal_urethra_morphology | 0.66844386 |
| 76 | MP0003938_abnormal_ear_development | 0.66706972 |
| 77 | MP0001502_abnormal_circadian_rhythm | 0.66533712 |
| 78 | MP0001661_extended_life_span | 0.65932691 |
| 79 | MP0002066_abnormal_motor_capabilities/c | 0.65676285 |
| 80 | MP0008770_decreased_survivor_rate | 0.65640085 |
| 81 | MP0004811_abnormal_neuron_physiology | 0.65338369 |
| 82 | MP0002067_abnormal_sensory_capabilities | 0.64617476 |
| 83 | MP0004043_abnormal_pH_regulation | 0.64603631 |
| 84 | MP0002557_abnormal_social/conspecific_i | 0.63287452 |
| 85 | MP0001486_abnormal_startle_reflex | 0.63283447 |
| 86 | MP0005452_abnormal_adipose_tissue | 0.62965933 |
| 87 | MP0001849_ear_inflammation | 0.61721859 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 0.61530888 |
| 89 | MP0005334_abnormal_fat_pad | 0.61019795 |
| 90 | MP0000569_abnormal_digit_pigmentation | 0.60453995 |
| 91 | MP0002115_abnormal_skeleton_extremities | 0.59972164 |
| 92 | MP0002064_seizures | 0.59839911 |
| 93 | MP0002069_abnormal_eating/drinking_beha | 0.59687561 |
| 94 | MP0001243_abnormal_dermal_layer | 0.59047279 |
| 95 | MP0002272_abnormal_nervous_system | 0.58741196 |
| 96 | MP0001970_abnormal_pain_threshold | 0.58489418 |
| 97 | MP0008057_abnormal_DNA_replication | 0.58133387 |
| 98 | MP0002735_abnormal_chemical_nociception | 0.57501595 |
| 99 | MP0002063_abnormal_learning/memory/cond | 0.55659869 |
| 100 | MP0003861_abnormal_nervous_system | 0.54483577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mask-like facies (HP:0000298) | 7.41165028 |
| 2 | Distal arthrogryposis (HP:0005684) | 7.33714161 |
| 3 | Exercise-induced myalgia (HP:0003738) | 7.20787469 |
| 4 | Nemaline bodies (HP:0003798) | 7.06826275 |
| 5 | Round ear (HP:0100830) | 6.80704742 |
| 6 | Calcaneovalgus deformity (HP:0001848) | 6.34816283 |
| 7 | Ulnar deviation of the wrist (HP:0003049) | 6.26154759 |
| 8 | Hyperkalemia (HP:0002153) | 5.87839080 |
| 9 | Muscle fiber inclusion bodies (HP:0100299) | 5.75114473 |
| 10 | Absent phalangeal crease (HP:0006109) | 5.74321625 |
| 11 | Deformed tarsal bones (HP:0008119) | 5.69345946 |
| 12 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.68098951 |
| 13 | Abnormal finger flexion creases (HP:0006143) | 4.83623035 |
| 14 | Periorbital edema (HP:0100539) | 4.81203180 |
| 15 | Facial edema (HP:0000282) | 4.61458531 |
| 16 | Type 1 muscle fiber predominance (HP:0003803) | 4.60800796 |
| 17 | Myopathic facies (HP:0002058) | 4.43452905 |
| 18 | Myoglobinuria (HP:0002913) | 3.97055020 |
| 19 | Exercise-induced muscle cramps (HP:0003710) | 3.79806398 |
| 20 | Neoplasm of the heart (HP:0100544) | 3.39302659 |
| 21 | Abnormality of potassium homeostasis (HP:0011042) | 3.28775931 |
| 22 | Difficulty running (HP:0009046) | 3.26154920 |
| 23 | Abnormality of the calcaneus (HP:0008364) | 3.21545095 |
| 24 | Down-sloping shoulders (HP:0200021) | 3.14277245 |
| 25 | Myotonia (HP:0002486) | 3.12275612 |
| 26 | Decreased circulating renin level (HP:0003351) | 2.98696429 |
| 27 | Metatarsus adductus (HP:0001840) | 2.93135774 |
| 28 | Nonprogressive disorder (HP:0003680) | 2.92276438 |
| 29 | Rhabdomyolysis (HP:0003201) | 2.66041146 |
| 30 | Increased connective tissue (HP:0009025) | 2.64862770 |
| 31 | Macroorchidism (HP:0000053) | 2.48954225 |
| 32 | Abnormality of the peritoneum (HP:0002585) | 2.39955113 |
| 33 | Hyperphosphatemia (HP:0002905) | 2.39685177 |
| 34 | Fibular aplasia (HP:0002990) | 2.29205444 |
| 35 | Bell-shaped thorax (HP:0001591) | 2.28043936 |
| 36 | Hypoventilation (HP:0002791) | 2.22670618 |
| 37 | Abnormality of the parietal bone (HP:0002696) | 2.22602988 |
| 38 | Intellectual disability, moderate (HP:0002342) | 2.21404969 |
| 39 | Muscle stiffness (HP:0003552) | 2.19133584 |
| 40 | Abnormality of the columella (HP:0009929) | 2.18867767 |
| 41 | 3-Methylglutaconic aciduria (HP:0003535) | 2.14843148 |
| 42 | Obstructive sleep apnea (HP:0002870) | 2.13159280 |
| 43 | Broad metatarsal (HP:0001783) | 2.10404028 |
| 44 | Abnormality of chloride homeostasis (HP:0011422) | 2.08612889 |
| 45 | Action tremor (HP:0002345) | 2.07140485 |
| 46 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.04021337 |
| 47 | Palpebral edema (HP:0100540) | 10.2020341 |
| 48 | Hypoplastic ischia (HP:0003175) | 1.98082873 |
| 49 | Microglossia (HP:0000171) | 1.96837138 |
| 50 | 2-3 toe syndactyly (HP:0004691) | 1.95049976 |
| 51 | Hypokalemia (HP:0002900) | 1.93034669 |
| 52 | Increased variability in muscle fiber diameter (HP:0003557) | 1.90923385 |
| 53 | Supernumerary ribs (HP:0005815) | 1.82755590 |
| 54 | Oligomenorrhea (HP:0000876) | 1.81674682 |
| 55 | Malignant hyperthermia (HP:0002047) | 1.80349618 |
| 56 | Menstrual irregularities (HP:0000858) | 1.76703199 |
| 57 | Coronal craniosynostosis (HP:0004440) | 1.74724351 |
| 58 | Broad-based gait (HP:0002136) | 1.74151514 |
| 59 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.70619624 |
| 60 | Tarsal synostosis (HP:0008368) | 1.69553308 |
| 61 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.69050263 |
| 62 | Synostosis involving bones of the feet (HP:0009140) | 1.69050263 |
| 63 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.66487693 |
| 64 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.66316524 |
| 65 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.65809879 |
| 66 | Delayed CNS myelination (HP:0002188) | 1.65143953 |
| 67 | Abnormality of incisor morphology (HP:0011063) | 1.64515759 |
| 68 | Broad hallux (HP:0010055) | 1.64465946 |
| 69 | Wrist flexion contracture (HP:0001239) | 1.62154074 |
| 70 | Abnormality of the ischium (HP:0003174) | 1.60457195 |
| 71 | Generalized muscle weakness (HP:0003324) | 1.60112817 |
| 72 | Shallow orbits (HP:0000586) | 1.59149268 |
| 73 | Type 2 muscle fiber atrophy (HP:0003554) | 1.55814155 |
| 74 | Hypoplastic iliac wings (HP:0002866) | 1.55787169 |
| 75 | Enlarged penis (HP:0000040) | 1.54062842 |
| 76 | Narrow palate (HP:0000189) | 1.51460816 |
| 77 | Mesomelia (HP:0003027) | 1.51097033 |
| 78 | Increased purine levels (HP:0004368) | 1.50770966 |
| 79 | Hyperuricemia (HP:0002149) | 1.50770966 |
| 80 | Metabolic acidosis (HP:0001942) | 1.50571139 |
| 81 | Nasolacrimal duct obstruction (HP:0000579) | 1.49072254 |
| 82 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.48943901 |
| 83 | Poor eye contact (HP:0000817) | 1.48018906 |
| 84 | Stenosis of the external auditory canal (HP:0000402) | 1.47366865 |
| 85 | Abnormal hair whorl (HP:0010721) | 1.45440106 |
| 86 | Progressive cerebellar ataxia (HP:0002073) | 1.40608126 |
| 87 | Shawl scrotum (HP:0000049) | 1.40514878 |
| 88 | Rectal prolapse (HP:0002035) | 1.40365346 |
| 89 | Sleep apnea (HP:0010535) | 1.37340810 |
| 90 | Abnormality of hair growth rate (HP:0011363) | 1.34281352 |
| 91 | Slow-growing hair (HP:0002217) | 1.34281352 |
| 92 | Adducted thumb (HP:0001181) | 1.33567205 |
| 93 | Absent speech (HP:0001344) | 1.33321143 |
| 94 | Gout (HP:0001997) | 1.32125828 |
| 95 | Agitation (HP:0000713) | 1.31630299 |
| 96 | Muscle fiber atrophy (HP:0100295) | 1.30973660 |
| 97 | Paralysis (HP:0003470) | 1.28952192 |
| 98 | Ulnar deviation of finger (HP:0009465) | 1.28685891 |
| 99 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.28453601 |
| 100 | Subaortic stenosis (HP:0001682) | 1.28414369 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PHKG1 | 5.83148861 |
| 2 | PHKG2 | 5.83148861 |
| 3 | OBSCN | 3.95548839 |
| 4 | TIE1 | 3.86924431 |
| 5 | WNK4 | 3.03378231 |
| 6 | TNIK | 2.99905722 |
| 7 | TYRO3 | 2.94347038 |
| 8 | CASK | 2.66451052 |
| 9 | CAMK1D | 2.56112525 |
| 10 | MAPK13 | 2.17767497 |
| 11 | WNK1 | 2.13495095 |
| 12 | CAMK1G | 2.08909774 |
| 13 | MARK1 | 1.98667402 |
| 14 | CAMKK2 | 1.89053991 |
| 15 | IRAK1 | 1.84632262 |
| 16 | JAK3 | 1.74559186 |
| 17 | DYRK1B | 1.73245721 |
| 18 | PIK3CA | 1.66134854 |
| 19 | FGFR2 | 1.64064128 |
| 20 | EPHB2 | 1.63857670 |
| 21 | PIK3CG | 1.41789660 |
| 22 | DYRK2 | 1.27841307 |
| 23 | PAK6 | 1.27263988 |
| 24 | CHEK2 | 1.16516952 |
| 25 | MAP3K12 | 1.11434270 |
| 26 | CAMKK1 | 1.09303764 |
| 27 | CDK4 | 1.07930851 |
| 28 | CAMK2G | 1.07161537 |
| 29 | LIMK1 | 1.06814403 |
| 30 | MOS | 1.06793254 |
| 31 | AURKA | 0.98086699 |
| 32 | NTRK2 | 0.97367671 |
| 33 | DDR2 | 0.97029104 |
| 34 | PRKD3 | 0.95874098 |
| 35 | DMPK | 0.94760886 |
| 36 | MAPK12 | 0.89312088 |
| 37 | NLK | 0.89092670 |
| 38 | MAP2K2 | 0.84985251 |
| 39 | NUAK1 | 0.83841343 |
| 40 | CSNK1G2 | 0.83517229 |
| 41 | RPS6KA2 | 0.82169732 |
| 42 | PINK1 | 0.81699971 |
| 43 | MARK2 | 0.80878438 |
| 44 | FGFR3 | 0.80108269 |
| 45 | CAMK4 | 0.79857006 |
| 46 | MAPK7 | 0.77281191 |
| 47 | SGK223 | 0.75191249 |
| 48 | SGK494 | 0.75191249 |
| 49 | SGK1 | 0.73561472 |
| 50 | CAMK1 | 0.71040242 |
| 51 | SGK2 | 0.69688452 |
| 52 | SCYL2 | 0.69327538 |
| 53 | PRKG1 | 0.66747392 |
| 54 | LMTK2 | 0.65417185 |
| 55 | STK39 | 0.63850286 |
| 56 | TAOK3 | 0.62853115 |
| 57 | CCNB1 | 0.62578656 |
| 58 | FRK | 0.61762597 |
| 59 | DYRK1A | 0.60848836 |
| 60 | MARK3 | 0.58730034 |
| 61 | TRIB3 | 0.54616791 |
| 62 | CSNK1A1L | 0.53973219 |
| 63 | TRPM7 | 0.53091240 |
| 64 | NTRK1 | 0.52669549 |
| 65 | TXK | 0.52205453 |
| 66 | CSNK1G1 | 0.52187554 |
| 67 | DYRK3 | 0.51964173 |
| 68 | MUSK | 0.51680182 |
| 69 | STK11 | 0.49183495 |
| 70 | SGK3 | 0.48799341 |
| 71 | TRIM28 | 0.48144936 |
| 72 | ILK | 0.47182950 |
| 73 | FES | 0.46593812 |
| 74 | BRD4 | 0.45796556 |
| 75 | CDK5 | 0.45603110 |
| 76 | DAPK2 | 0.45540370 |
| 77 | RPS6KA3 | 0.45451367 |
| 78 | BMPR1B | 0.41046055 |
| 79 | PRKD2 | 0.39976421 |
| 80 | EIF2AK2 | 0.39360607 |
| 81 | TEC | 0.39134127 |
| 82 | PRKACB | 0.36870204 |
| 83 | CDK12 | 0.35712682 |
| 84 | PKN1 | 0.33557734 |
| 85 | CSNK1G3 | 0.33372449 |
| 86 | MAP2K4 | 0.33055458 |
| 87 | STK3 | 0.32262852 |
| 88 | OXSR1 | 0.28948272 |
| 89 | INSRR | 0.28787760 |
| 90 | MAP3K7 | 0.26637443 |
| 91 | SIK2 | 0.26115690 |
| 92 | TESK2 | 0.25242504 |
| 93 | PRKDC | 0.25048435 |
| 94 | PRKACA | 0.23590479 |
| 95 | MAPK8 | 0.23511835 |
| 96 | TESK1 | 0.23400658 |
| 97 | AKT1 | 0.23075991 |
| 98 | MINK1 | 0.22564067 |
| 99 | PRKCE | 0.21758203 |
| 100 | RPS6KA6 | 0.21071439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Tight junction_Homo sapiens_hsa04530 | 5.03071726 |
| 2 | Regulation of autophagy_Homo sapiens_hsa04140 | 3.30346003 |
| 3 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.53188367 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.36935485 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 1.99579952 |
| 6 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.95701876 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.95601121 |
| 8 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.94339039 |
| 9 | Renin secretion_Homo sapiens_hsa04924 | 1.93475994 |
| 10 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.91074090 |
| 11 | Ribosome_Homo sapiens_hsa03010 | 1.88677554 |
| 12 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.87492585 |
| 13 | Long-term depression_Homo sapiens_hsa04730 | 1.79981782 |
| 14 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.78172328 |
| 15 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.76791158 |
| 16 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.74783235 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.72395040 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 1.70017747 |
| 19 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.69438771 |
| 20 | Long-term potentiation_Homo sapiens_hsa04720 | 1.69319039 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.65097662 |
| 22 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.59999111 |
| 23 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.55897808 |
| 24 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.45466918 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.45100247 |
| 26 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.44982718 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.44921676 |
| 28 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.44023205 |
| 29 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.41427660 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.35439772 |
| 31 | Adherens junction_Homo sapiens_hsa04520 | 1.34418828 |
| 32 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.32537501 |
| 33 | GABAergic synapse_Homo sapiens_hsa04727 | 1.31910490 |
| 34 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.31678155 |
| 35 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.31471022 |
| 36 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.27199994 |
| 37 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.24919237 |
| 38 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.12680661 |
| 39 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.12056996 |
| 40 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.11286478 |
| 41 | Circadian rhythm_Homo sapiens_hsa04710 | 1.11139574 |
| 42 | Phototransduction_Homo sapiens_hsa04744 | 1.11029160 |
| 43 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.10749968 |
| 44 | Axon guidance_Homo sapiens_hsa04360 | 1.09293428 |
| 45 | Nicotine addiction_Homo sapiens_hsa05033 | 1.08400124 |
| 46 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.00364451 |
| 47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.93863827 |
| 48 | Melanogenesis_Homo sapiens_hsa04916 | 0.93849386 |
| 49 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.92912472 |
| 50 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.92436867 |
| 51 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.88693165 |
| 52 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.86342205 |
| 53 | Olfactory transduction_Homo sapiens_hsa04740 | 0.86183223 |
| 54 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84635136 |
| 55 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84049359 |
| 56 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.83749520 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.81327063 |
| 58 | Salivary secretion_Homo sapiens_hsa04970 | 0.76945669 |
| 59 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.74944552 |
| 60 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.71703703 |
| 61 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.69263057 |
| 62 | Glioma_Homo sapiens_hsa05214 | 0.68779457 |
| 63 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66715502 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.64275575 |
| 65 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63119852 |
| 66 | Spliceosome_Homo sapiens_hsa03040 | 0.61586350 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.60651433 |
| 68 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59806521 |
| 69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58845043 |
| 70 | Gap junction_Homo sapiens_hsa04540 | 0.58500150 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58423305 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.58422986 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57270802 |
| 74 | Alzheimers disease_Homo sapiens_hsa05010 | 0.56735693 |
| 75 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.56646441 |
| 76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55136239 |
| 77 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54206143 |
| 78 | RNA degradation_Homo sapiens_hsa03018 | 0.52532968 |
| 79 | Cocaine addiction_Homo sapiens_hsa05030 | 0.52512644 |
| 80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52440850 |
| 81 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.51366975 |
| 82 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50104347 |
| 83 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47564896 |
| 84 | Taste transduction_Homo sapiens_hsa04742 | 0.47511444 |
| 85 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.45768559 |
| 86 | Melanoma_Homo sapiens_hsa05218 | 0.43201513 |
| 87 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.42790869 |
| 88 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42000400 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40505191 |
| 90 | Alcoholism_Homo sapiens_hsa05034 | 0.39054242 |
| 91 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38736158 |
| 92 | ABC transporters_Homo sapiens_hsa02010 | 0.38371147 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38204271 |
| 94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.36838629 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35012823 |
| 96 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.34095510 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.34073759 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32887281 |
| 99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32267196 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32156029 |

